{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:33:20Z","timestamp":1773423200005,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.jaad.2006.02.059","type":"journal-article","created":{"date-parts":[[2006,8,29]],"date-time":"2006-08-29T08:21:22Z","timestamp":1156839682000},"page":"S68-S72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"S","title":["Bullous pemphigoid associated with hypereosinophilic syndrome: Simultaneous response to imatinib"],"prefix":"10.1016","volume":"56","author":[{"given":"Silke C.","family":"Hofmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Technau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia M.S.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"L\u00fcbbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"Bruckner-Tuderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2006.02.059_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2141.2003.04195.x","article-title":"The eosinophilias, including the idiopathic hypereosinophilic syndrome","volume":"121","author":"Brito-Babapulle","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2006.02.059_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/archderm.1978.01640160009003","article-title":"Dermatologic manifestations of the hypereosinophilic syndrome","volume":"114","author":"Kazmierowski","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.02.059_bib3","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2003-01-0081","article-title":"Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome","volume":"101","author":"Cortes","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2006.02.059_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195302000-00001","article-title":"Pemphigus","volume":"32","author":"Lever","year":"1953","journal-title":"Medicine"},{"key":"10.1016\/j.jaad.2006.02.059_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/1523-1747.ep12874652","article-title":"Studies of the relationship of the 230-kDa and 180-kDa bullous pemphigoid antigens","volume":"94","author":"Robledo","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.02.059_bib6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jaad.2004.02.013","article-title":"Management of autoimmune bullous diseases: pharmacology and therapeutics","volume":"51","author":"Mutasim","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.02.059_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1365-2133.2000.03599.x","article-title":"Elevated levels of eotaxin and interleukin-5 in\u00a0blister fluid of bullous pemphigoid: correlation with tissue eosinophilia","volume":"143","author":"Wakugawa","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.059_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/cyto.2000.0791","article-title":"Bullous pemphigoid interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation","volume":"13","author":"Engineer","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.jaad.2006.02.059_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2133.2000.03750.x","article-title":"Hypereosinophilic dermatosis: skin lesions as the only manifestation of the idiopathic hypereosinophilic syndrome?","volume":"143","author":"Offidani","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.059_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/adc.62.6.601","article-title":"The idiopathic hypereosinophilic syndrome","volume":"62","author":"Alfaham","year":"1987","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaad.2006.02.059_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-005-1084-7","article-title":"Imatinib mesylate as a novel treatment option for hypereosinophilic syndrome: two case reports and a comprehensive review of the literature","volume":"85","author":"M\u00fcller","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jaad.2006.02.059_bib12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.2005.06662.x","article-title":"Annual incidence and mortality of bullous pemphigoid in the Grampian region of north-east Scotland","volume":"153","author":"Gudi","year":"2005","journal-title":"Br\u00a0J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.059_bib13","article-title":"Pemphigoide et syndrome hyper\u00e9osinophilique d'\u00e9volution fatale","volume":"127","author":"Gscheidel","year":"2000","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2006.02.059_bib14","first-page":"1291","article-title":"[Idiopathic hypereosinophilic syndrome and bullous pemphigoid.]","volume":"129","author":"Belgnaoui","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2006.02.059_bib15","article-title":"[Pemphigoid nodularis triggered by hypereosinophilic syndrome?]","author":"Felbert","year":"2005","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaad.2006.02.059_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0165-4608(95)00260-X","article-title":"Deletion of chromosome 20q associated with hypereosinophilic syndrome. A report of two cases","volume":"87","author":"Brigaudeau","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.jaad.2006.02.059_bib17","first-page":"224","article-title":"Karyotype and molecular cytogenetic studies in polycythemia vera","volume":"4","author":"Andrieux","year":"2005","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.jaad.2006.02.059_bib18","first-page":"1168","article-title":"Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes","volume":"90","author":"Sole","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.jaad.2006.02.059_bib19","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2006.02.059_bib20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1523-1747.2002.19529.x","article-title":"Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain","volume":"119","author":"Hofmann","year":"2002","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.02.059_bib21","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1001\/archderm.140.12.1496","article-title":"Bullous pemphigoid associated with mantle cell lymphoma","volume":"140","author":"Iranzo","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.02.059_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000085559","article-title":"Molecular classification and pathogenesis of eosinophilic disorders: 2005 Update","volume":"114","author":"Gotlib","year":"2005","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jaad.2006.02.059_bib23","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1172\/JCI117196","article-title":"92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen","volume":"93","author":"Stahle-Backdahl","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2006.02.059_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/path.1674","article-title":"Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid","volume":"204","author":"Shimanovich","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.jaad.2006.02.059_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0092-8674(00)00087-8","article-title":"The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B\/MMP-9 in vivo","volume":"102","author":"Liu","year":"2000","journal-title":"Cell"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206006165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206006165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:05:20Z","timestamp":1759269920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962206006165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0190962206006165"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2006.02.059","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bullous pemphigoid associated with hypereosinophilic syndrome: Simultaneous response to imatinib","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2006.02.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}